The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of front-line chemotherapy for recurrent/metastatic adenosarcoma of the uterus.
 
Michael Nathenson
No Relationships to Disclose
 
Anthony Paul Conley
No Relationships to Disclose
 
Ravin Ratan
No Relationships to Disclose
 
Maria Alejandra Zarzour
No Relationships to Disclose
 
Neeta Somaiah
Honoraria - Immune Design
Travel, Accommodations, Expenses - Immune Design
 
Dejka M. Araujo
No Relationships to Disclose
 
Shreyaskumar Patel
Consulting or Advisory Role - CytRx Corporation; Daiichi Sankyo; EMD Serono; Johnson & Johnson; Novartis
Research Funding - Eisai (Inst); Johnson & Johnson (Inst); Morphotek (Inst); PharmaMar (Inst)
 
Robert S. Benjamin
Stock and Other Ownership Interests - Express Scripts (I); Gilead Sciences (I); Johnson & Johnson (I); Merck Serono (I); Pfizer (I)
Consulting or Advisory Role - Karyopharm Therapeutics; Lilly; Novartis
Travel, Accommodations, Expenses - PharmaMar
 
Vinod Ravi
No Relationships to Disclose